>
MedMira Inc logo

MIR - MedMira Inc Share Price

C$0.235 0.0  2.2%

Last Trade - 13/04/21

Sector
Healthcare
Size
Small Cap
Market Cap £89.7m
Enterprise Value £96.4m
Revenue £1.56m
Position in Universe 730th / 2712
Bullish
Bearish
Unlock MIR Revenue
Momentum
Relative Strength (%)
1m -14.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -73.6%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Jul 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
4.05 2.26 0.75 0.59 0.53 0.92 -25.7%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 January 2021, MedmiraInc revenues increased from C$184K to C$2M. Net incometotaled C$299K vs. loss of C$1.1M. Revenues reflect Productsales increase from C$184K to C$1.9M. Net Income reflectsGeneral and administrative decrease of 49% to C$278K(expense), Finance costs decrease of 9% to C$336K(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

MIR Revenue Unlock MIR Revenue

Net Income

MIR Net Income Unlock MIR Revenue

Normalised EPS

MIR Normalised EPS Unlock MIR Revenue

PE Ratio Range

MIR PE Ratio Range Unlock MIR Revenue

Dividend Yield Range

MIR Dividend Yield Range Unlock MIR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
MIR EPS Forecasts Unlock MIR Revenue
Profile Summary

MedMira Inc. is a biotechnology company. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company operates through the rapid diagnostic products and services segment. The Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its research focuses on specific areas of the diagnostics market, such as rapid, point-of-care and in vitro sectors. The RVF technology platform includes a three component system: a test cartridge, multi-function buffer and InstantGold Cap. Its technology can be applied in healthcare, research and industrial markets. It offers rapid tests for testing serum, plasma or whole blood specimens. The Company's tests are sold under brands, including Reveal, Multiplo and Miriad. The Company offers rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis.

Directors
Last Annual July 31st, 2020
Last Interim January 31st, 2021
Incorporated July 26, 1999
Public Since December 1, 1999
No. of Shareholders: n/a
No. of Employees: 65
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange TSX Venture Exchange
Shares in Issue 658,664,320
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MIR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MIR
Upcoming Events for MIR
Frequently Asked Questions for MedMira Inc
What is the MedMira Inc share price?

As of 13/04/21, shares in MedMira Inc are trading at C$0.235, giving the company a market capitalisation of £89.7m. This share price information is delayed by 15 minutes.

How has the MedMira Inc share price performed this year?

Shares in MedMira Inc are currently trading at C$0.235 and the price has moved by 0.667k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the MedMira Inc price has moved by 0.461k% over the past year.

What are the analyst and broker recommendations for MedMira Inc?

There are no analysts currently covering MedMira Inc.

When will MedMira Inc next release its financial results?

MedMira Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-01-31
What is the MedMira Inc dividend yield?

MedMira Inc does not currently pay a dividend.

Does MedMira Inc pay a dividend?

MedMira Inc does not currently pay a dividend.

When does MedMira Inc next pay dividends?

MedMira Inc does not currently pay a dividend.

How do I buy MedMira Inc shares?

To buy shares in MedMira Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of MedMira Inc?

Shares in MedMira Inc are currently trading at C$0.235, giving the company a market capitalisation of £89.7m.

Where are MedMira Inc shares listed? Where are MedMira Inc shares listed?

Here are the trading details for MedMira Inc:

Country of listing: Canada
Exchange: CVE
Ticker Symbol: MIR
What kind of share is MedMira Inc?

Based on an overall assessment of its quality, value and momentum, MedMira Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a MedMira Inc share price forecast 2021?

We were not able to load any forecast data for MedMira Inc.

How can I tell whether the MedMira Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like MedMira Inc. Over the past six months, the relative strength of its shares against the market has been -33.09%. At the current price of C$0.235, shares in MedMira Inc are trading at -25.18% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the MedMira Inc PE Ratio?

We were not able to find PE ratio data for MedMira Inc.

Who are the key directors of MedMira Inc?

MedMira Inc's management team is headed by:

Hermes Chan - CEO
Steven Cummings - IND
Markus Meile - CFO
Jianhe Mao - IND
Who are the major shareholders of MedMira Inc?

Here are the top five shareholders of MedMira Inc based on the size of their shareholding:

MedMira Holding AG Corporation
Percentage owned: 72.01% (474.1m shares)
Chan (Hermes) Individual Investor
Percentage owned: 0.47% (3.11m shares)
Similar to MIR
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.